The enormous library of pharmaceutical compounds presents endless research avenues.
However, several factors limit the therapeutic potential of these drugs, such as drug …

A variety of neuroprotectants have shown promise in treating ischemic stroke, yet their
delivery to the brain remains a challenge. The endothelial cells lining the blood-brain barrier …

Gene editing-based therapeutic strategies grant the power to override cell machinery and
alter faulty genes contributing to disease development like cancer. Nowadays, the principal …

Recently, red blood cell-derived extracellular vesicles (RBCEVs) have attracted attention for
clinical applications because of their safety and biocompatibility. RBCEVs can escape …

Triple-negative breast cancer (TNBC) is a rapidly recurring and highly metastatic
malignancy with high heterogeneity and chemoradiotherapy resistance. Chronic …

The underlying cause of cancer is genetic disruption, so gene editing technologies,
particularly CRISPR/Cas systems can be used to go against cancer. The field of gene …

Gene therapy is a therapeutic strategy of delivering foreign genetic material (encoding for an
important protein) into a patient's target cell to replace a defective gene. Nucleic acids are …

In this article, a review of a series of applications of atomic force microscopy (AFM) and
fluidic Atomic Force Microscopy (fluidic AFM, hereafter fluidFM) in single‐cell studies is …

Simple Summary In recent years, immunotherapy has shown great advancement, becoming
a powerful tool to combat cancer. In this context, the use of biologically derived vesicles has …

Extracellular vesicles are membrane-bound nanoparticles secreted by cells which play a
well-known role in cell to cell communication. The most update to date nomenclature …